E. ANN BURGESS AND B. LEVIN
There are two main groups of conditions in which the determination of enzyme activities in tissues is necessary or desirable. They are (a) primary defects of enzyme synthesis and (b) alterations of enzyme activity secondary to damage of the cell. Since the time of Garrod, hereditary metabolic disorders have been recognized to be due to a defect of one or perhaps more enzymes, which may have farreaching metabolic consequences and produce multiple biochemical and other abnormalities. This communication is confined to enzyme assays using tissues from organs such as liver, kidney, or gastrointestinal mucosa and including the leucocytes of the blood. It excludes the examination of blood plasma, the enzymes of which are, of course, not synthesized there, but accumulate by leakage from the organs it bathes or from degradation of red and white blood cells. A general review of methods of enzyme assay is not attempted, but the principles of the methods used for individual enzyme assays are *emphasized. Selection has been based on the special factors which must be taken into account in this field, eg, the limited amount of material available so that the sensitivity of a method is important, and the fact that tissues contain a mixture of enzymes as well as many different substrates. The methods of assay available for pure enzymes are not always applicable to a crude tissue homogenate.
Tissues Used for Enzyme Assays (Table) The organ most commonly involved in hereditary metabolic disorders is the liver, which is therefore the tissue most frequently biopsied. A specimen can be obtained either by percutaneous needle aspiration or by open biopsy. It is always desirable to examine as many enzymes as possible of the metabolic sequence in which the block is thought to occur. This is necessary for two reasons. First, there not infrequently appears to be alteration of the activity of another enzyme of the pathway besides the defective one; this may be a genuine defect of two enzymes simultaneously, as has been reported in certain types of glycogen storage disease (Auerbach and DiGeorge, 1965; Parr, Teree, and Larner, 1965 Jejunal biopsies are usually taken when malabsorption is suspected, in order to measure the enzymes concerned with the absorption of carbohydrate or protein. However, the jejunal mucosa has an enzyme pattern which resembles that of liver more closely than that of leucocytes, and it is sometimes examined instead of liver because a jejunal biopsy is more easily performed. A disadvantage is that the biopsies are very small, only 20-30 mg in weight. Muscle biopsies are readily obtained when enzyme patterns are to be studied in muscle disorders.
Enzymes of Similar Function in Different Tissues
The major disadvantage of using tissues other than liver is that enzyme patterns are not necessarily uniform among organs. The early assumption that a genetic defect resulting in an enzyme deficiency was uniformly present in all the cells of the body is not 25 I 20 15 10 now thought to be correct. Although an enzyme found to be abnormal in white blood cells, skin, or jejunum is generally, although not invariably, abnormal in the liver, the reverse cannot be assumed; for enzymes have been found to be abnormal in liver when normal in leucocytes or jejunum of the same patient. Thus a normal glycogen phosphorylase (EC 2.4.1.1.) activity in white blood cells of a case of glycogen storage disease cannot be accepted as proof that no abnormality of the liver enzyme exists (Ockerman, Jelke, and Kaijser, 1966) . Similarly, in one case of fructosaemia, the liver fructose 1-phosphate aldolase (EC 4.1.2.7) activity was reduced, while the activity in jejunal mucosa was normal (Levin, Snodgrass, Oberholzer, Burgess, and Dobbs, 1968) . Such a divergence between two tissues may be related to the existence of isoenzymes, only one of which may be affected.
Study of Other Properties of Enzymes than Activity
A metabolic defect may sometimes occur when the enzyme activity in vitro appears to be normal or only slightly below the normal range. However, provided sufficient tissue is available it may be possible to show by the measurement of other properties of the enzyme that the enzyme is abnormal. For example the Michaelis constant (Km) of an enzyme may be determined as a measure of its affinity for its (Levin, Dobbs, Burgess, and Palmer, 1969) . This pointed to a defect in enzyme structure sufficient probably to cause a marked decrease in enzyme activity in vivo ( Fig. 1) . Again, the lactate dehydrogenase (EC 1.1.1.27) of muscle from muscular dystrophy has not the isoenzyme pattern of normal muscle. There is some evidence from starch gell electrophoresis that the lactate dehydrogenase from the liver of one infant with lactic acidaemia had an abnormal isoenzyme pattern although the total activity was within the normal range (B. Levin genate is made in isotonic sucrose solution so that they can be separated by differential centrifugation. Muscle needs to be cut roughly with scissors before homogenizing, and a loose-fitting homogenizer is used. For liver and intestine, it is better to use a tight-fitting homogenizer.
Methods of Enzyme Assay
The activity of an enzyme is determined from the rate at which the catalysed reaction proceeds. Two general methods are available for performing enzyme assays. In the first, a homogenate is incubated at 37°C in a medium buffered at a suitable pH and containing the substrate and any cofactors required. Aliquots are removed at zero time and at timed intervals thereafter, each being pipetted into a protein precipitant, which stops the reaction. Provided there is enough tissue available, it is advisable to take samples at several timed intervals. This is preferable to performing the assay in duplicate at one time interval, since it ensures that the reaction is proceeding linearly, while providing more than one reading to eliminate errors. The amount of substrate used or of product formed is then measured.
In the second method the reagent mix is actually incubated in the spectrophotometer cuvette, and the change in concentration of one of the components of the reaction is directly followed by measuring the absorption at the required wavelength at suitable intervals of time. This method is used especially for dehydrogenase reactions, where advantage is taken of the absorption at 340 nm of reduced pyridine nucleotides.
The concentration of the homogenate and time of incubation must be selected to ensure that the reaction studied proceeds linearly over the period of the incubation. A high concentration of substrate should be present, so that there is an excess during the whole course of the reaction; a concentration of five to ten times the smallest amount necessary to produce the maximum rate of enzyme reaction is usually used. This can be calculated from the Michaelis constant of the enzyme if this is known.
An example of a poorly devised assay method from this point of view is one commonly described for the assay of red cell galactose 1-phosphate uridyltransferase (EC 2.7.7.10) activity (Fig. 2) . This recommends that one reading only be taken after 30 minutes' incubation. Calculation from this yields normal levels of 1 7-9-0 units/gHb as usually quoted. However, if several timed samples are removed for assay of residual UDPglucose, it becomes apparent that the reaction is not linear over this period and a much higher normal range is found if the results are calculated from the initial part of the curve which is linear. This may not be important in judging whether or not an enzyme is present or absent for the purpose of diagnosis of the condition, but becomes important if the heterozygote state is to be detected.
After the incubation, the reaction product is assayed in the protein-free filtrate. This can often be done in the presence of the substrate, as for example with glucose 6-phosphatase (Fig. 3) where inorganic phosphate is measured in the presence of the acid stable glucose 6-phosphate, or with ornithine carbamoyltransferase, where citrulline is assayed in the presence of ornithine. Often, however, the product, being chemically similar to the substrate, cannot be assayed in its presence. The two may then be separated by paper chromatography or electrophoresis so that they may be measured separately as in the case of methylmalonyl-CoA mutase (Oberholzer et al, 1967) . When the product of the~0 Reaction: G-6-P -CGlucose + inorganic phosphate. The increase in inorganic phosphate is measured. enzyme under study inhibits the enzyme reaction, or is unstable, it can be converted in situ by a second enzyme system, using the product of the initial reaction as its substrate. This second enzyme is added in excess, so that conversion of the product is quantitative. The final end product is then assayed in the protein-free filtrate.
It is important to consider also the relationship of the enzyme to be assayed to other enzymes and to the metabolic pathway involved. There may be present in the homogenate other enzymes which are likely to compete for the substrate, or subsequent enzymes of the pathway may act upon the product of the reaction under examination so that it cannot now be accurately measured. Thus the method mentioned above for the assay of galactose 1-phosphate uridyltransferase in red cells cannot be used with liver since UDPglucose epimerase (EC 5.1.3.2.) will reconvert UDPgalactose to UDPglucose. For its assay in liver, the glucose 1-phosphate is determined by conversion to glucose 6-phosphate by adding phosphoglucomutase (EC 2.7.5.1.) (Roth, Segal, and Bertoli, 1965) .
Enzymes which catalyse a single reaction, eg, the disaccharidases or which, although in a metabolic sequence, yield a product which does not undergo further change, eg, arginase, can usually be readily assayed by measuring the product. On the other hand, two enzymes of the urea cycle, argininosuccinate synthetase (EC 6.3.4.5) and argininosuccinate (EC 4.3.2.1) lyase, may be measured by encouraging their products to continue quantitatively to the formation of urea by adding purified arginase to the reaction mixture.
In some cases where the enzyme to be measured forms part of a metabolic pathway, the immediate product does not accumulate quantitatively, nor can the final product of the pathway be quantitatively produced. This difficulty can be overcome by adding an inhibitor of the subsequent enzyme of the sequence, thus allowing the product of the reaction to accumulate. For example, when fructose-diphosphate aldolase (EC 4.1.2.13), an enzyme in the glycolytic pathway, is assayed in liver or muscle biopsies, iodoacetate can be added as inhibitor of the next reaction in the glycolytic sequence; in this case it is also necessary to remove the products of the reaction, glyceraldehyde phosphate and dihydroxyacetone phosphate, as they are formed, since if allowed to accumulate they inhibit the activity of the aldolase. Both products form hydrazones so that hydrazine hydrate is added to prevent their inhibitory action.
An alternative method of assaying an enzyme in the middle of a metabolic sequence is to measure the rate of disappearance of the substrate. Thus, methylmalonyl-CoA mutase converts methylmalonyl-CoA to succinyl-CoA which cannot be assayed because it is metabolised by the tricarboxylic acid cycle. Its further metabolism could be suppressed by malonic acid which inhibits succinate dehydrogenase (EC 1.3.99.1) were it not for the fact that malonic acid also inhibits methylmalonyl-CoA mutase.
An enzyme from a different or an opposing metabolic sequence may utilize either the same substrate or the cofactors of the enzyme being studied. Thus, when ATP is an obligatory cofactor in a reaction, it is necessary to ensure that neither the specific ATP-ase (EC 3.6.1.3.) nor nonspecific phosphatases destroy the ATP. Since fluoride is an effective inhibitor of ATP-ases, it is sometimes helpful to add this, provided that it does not also inhibit the enzyme under study. One way of removing ATPase is to remove the microsomes by centrifugation since they contain the highest concentration of E. Ann Burgess and B. Levin ATP-ase. A more convenient method is to add an ATP-regenerating system such as phosphoenolpyruvate and pyruvate kinase (EC 2.7.1.40).
Summary and Conclusion
The purpose of emphasizing the difficulties involved in the assay of enzymes in tissues is to point out that the methods developed for the assay of purified enzymes cannot be applied without modification to the assay of the enzymes in a tissue homogenate. Proper attention must be given to the preparation of the tissue and indiscriminate deep freezing is to be avoided. Provided the conditions are chosen so that the reaction is linear over the period of assay, methods which are relatively simple to perform can be devised for the assay of most of the enzymes of interest in metabolic defects. The finding of absent or low activity of one enzyme together with a normal activity of other enzymes in the same sequence is sufficient to show the cause of the metabolic abnormality. This does not establish in itself whether the enzyme protein has been completely deleted or whether there is a normal amount of enzyme protein with an abnormal structure. The presence of enzymes with abnormal Km values in some instances of metabolic block suggests that the second possibility may sometimes be the case. For this reason it is interesting to study the properties of the enzyme as well as measuring its activity. It is often necessary to assay several enzymes of a metabolic sequence under inve3tigation, not only to prove that one defective enzyme activity exists, but that other enzymes of the series are normal.
